Sirolimus-eluting stents for the treatment of in-stent restenosis

Minerva Cardioangiologica

Volumn 51, Issue 5, 2003, Pages 475-484

  Degertekin, M ^a   Saia, F ^a   Lemos, P A ^a   Arampatzis, C A ^a   Serruys, P W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary disease; Coronary restenosis; Sirolimus; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FK 506 BINDING PROTEIN; RAPAMYCIN;

ARTERY INTIMA PROLIFERATION; BETA RADIATION; BRACHYTHERAPY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DIRECTIONAL ATHERECTOMY; DRUG ELUTING STENT; GAMMA RADIATION; HUMAN; INTRAVASCULAR ULTRASOUND; RESTENOSIS; REVIEW; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; REGISTRIES; SIROLIMUS; STENTS;

EID: 0347419516     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-95.
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
3. Faxon D, Williams D, Yeh W, Mehra A, Houbokov R, Detre K. Improved in-hospital outcome with expanded use of coronary stents: results from the NHLBI dynamic registry. J Am Coll Cardiol 1999;33 Suppl A:91A.
4. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-6.
5. Lowe HC, Oesterle SN, Khachigian LM. Coronary instent restenosis: current status and future strategies. J Am Coll Cardiol 2002;39:183-93.
6. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. Restenosis after experimental angioplasty, Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res 1995;76:996-1002.
7. Schwartz RS, Topol EJ, Serruys PW, Sangiorgi G, Holmes DR Jr. Artery size, neointima, and remodeling: time for some standards. J Am Coll Cardiol 1998;32:2087-94.
8. Sobel BE. Acceleration of restenosis by diabetes: pathogenetic implications. Circulation 2001;103:1185-7.
9. Mintz GS, Popma JJ, Pichard AD, Kent KM, Salter LF, Chuang YC et al. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol 1996;27:1678-87.
10. Prati F, Di Mario C, Moussa I, Reimers B, Mallus MT, Patina A et al. In-stem neointimal proliferation correlates with the amount of residual plaque burden outside the stent: an intravascular ultrasound study. Circulation 1999;99:1011-4.
11. Kornowski R, Hong MK. Tio FO, Bramwell O, Wu H, Leon MB. In-stem restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-30
12. de Feyter PJ, Kay P, Disco C, Serruys PW. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 1999;100:1777-83.
13. Kosokabe T, Okumura K, Sone T, Kondo J, Tsuboi H, Mukawa H et al. Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting. Circulation 2001;103:2048-54.
14. Kastrati A. Schomig A, Seyfarth M, Koch W, Elezi S, Bottiger C et al. PIA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 1999;99:1005-10.
15. Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann FJ et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000;36:2168-73.
16. Koster R, Vieluf D, Kiehn M, Sommerauer M, Kahler J, Baldus S et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000;356:1895-7.
17. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8.
18. Mehran R, Mintz GS, Popma JJ, Pichard AD, Satler LF, Kent KM et al. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 1996;78:618-22.
19. Mahdi NA, Pathan AZ, Harrell L, Leon MN, Lopez J, Butte A et al. Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. Am J Cardiol 1998;82:1345-51.
20. Harrington RA, Lincoff AM, Califf RM, Holmes DR Jr., Berdan LG, O'Hanesian MA et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty versus Excisional Atherectomy Trial (CAVENT). J Am Coll Cardiol 1995;25:1693-9.
21. Sharma SK, Kini A, King T, Dangas G, Cocke TP. Randomised Trial of Rotational Atherectomy versus Balloon Angioplasty for In-stent Restenosis (ROSTER): interim analysis of 150 cases. Eur Heart J 1999;20:281A.
22. Vom Dahl J, Dietz U, Haager PK, Silber S, Niccoli L. Buettner HJ et al. Rotational Atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis (ARTIST). Circulation 2002;105: 583-8.
23. Mehran R, Mintz GS, Satler LF, Pichard AD, Kent KM, Bucher TA et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. Circulation 1997; 96:2183-9.
24. Adamian M, Colombo A, Briguori C, Nishida T, Marsico F, Di Mario C et al. Cutting balloon angioplasty for the treatment of in-Stent restenosis: a matched Comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol 2001;38:672-9.
25. Mehran R, Dangas G, Abizaid A, Lansky AJ, Mintz GS, Pichard AD et al. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results. Am Heart J 2001;141: 610-4.
26. Di Mario C, Marsico F, Adamian M, Karvouni E, Albiero R, Colombo A. New recipes for in-stent restenosis: cut, grate, roast, or sandwich the neointima? Heart 2000;84: 471-5.
27. Alfonso F, Cequier A, Zueco J, Moris C, Suarez CP, Colman T et al. Stenting the stent: initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis. Am J Cardiol 2000;85:327-32.
28. Costa MA, Sabate M. van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999;100: 789-92.
29. Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995;76:412-7.
30. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996;98:2277-83.
31. Zohlnhofer D, Klein CA, Richter T, Brandl R, Murr A, Nuhrenberg T et al. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-Binding Protein 12 Upregulation. Circulation 2001;103:1396-402.
32. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: 1-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-011.
33. Degertekin M, Serruys PW, Foley DP, Tanabe K, Regar E, Vos J et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002;106: 1610-3.
34. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
35. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C et al. Angiographic and clinical outcomes after a sirolimus-eluting stent compared to a standard stent in patients with native coronary artery stenoses. N Engl J Med. In press 2003.
36. Directive 96/29/Euratom. Official Journal L;159:0001-0114.
37. Albiero R, Nishida T, Adamian M, Amato A, Vaghelti M, Corvaja N, Di Mario C et al. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation 2000;101:2454-7.
38. Sabate M, Costa MA, Kozuma K, Kay IP, van Der Giessen WJ, Coen VL et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation 2000;101:2467-71.
39. Kay IP, Sabate M, Van Langenhove G, Costa MA, Wardeh AJ, Gijzel AL et al. Outcome from balloon induced coronary artery dissection after intracoronary beta radiation. Heart 2000;83:332-7.
40. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003;107:559-64.
41. Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and 3-dimensional intravascular ultrasound study. Circulation 2003;107:24-7.
42. Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis. The first clinical experience. J Am Coll Cardiol 2003;41:184-9.
43. Saia F, Lemos PA, Degertekin M, Regar E, Arampatzis CA, Lee CH et al. Sirolimus-eluting stents for treatment of in-stent restenosis in the real world: preliminary results from the Rapamycin Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry. J Aro Coll Cardiol 2003;41Suppl 1:27A.
44. Lemos PA, Lee C, Degertekin M, Saia F, Tanabe K, Arampatzis CA et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. Insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 2003;41: 2093-9.42.
45. Saia F, Lemos PA, Sianos G, Degertekin M, Lee CH, Arampatzis CA et al. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Am J Cardiol 2003;92:200-3.
46. Glover C, Ma X, Chen YX, Miller H, Veinot J, Labinaz M et al. Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J 2002;144:702-9.
47. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
48. Koyama H, Reidy MA. Expression of extracellular matrix proteins accompanies lesion growth in a model of intimal reinjury. Circ Res 1998;82:988-95.
49. Koyama H, Reidy MA. Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Circ Res 1997;80:408-17.
50. Liistro F, Stankovic G, Di Mario C, Takagi T, Chieffo A, Moshiri S et al. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation 2002;105: 1883-6.
51. Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS et al. Two-year angiograplaic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107:381-3.
52. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003;107: 2178-80.
53. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K et al. Coronary restenosis after sirolimus-eluting stent implantation. Morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003. In press 2003.